BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19684518)

  • 1. Primary central nervous system lymphoma: an update.
    Soussain C; Hoang-Xuan K
    Curr Opin Oncol; 2009 Nov; 21(6):550-8. PubMed ID: 19684518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary central nervous system lymphoma.
    Abrey LE
    Curr Opin Neurol; 2009 Dec; 22(6):675-80. PubMed ID: 19741527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment options for central nervous system lymphomas in immunocompetent patients.
    Jahnke K; Thiel E
    Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of primary central nervous system lymphoma.
    Tang YZ; Booth TC; Bhogal P; Malhotra A; Wilhelm T
    Clin Radiol; 2011 Aug; 66(8):768-77. PubMed ID: 21513925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A retrospective analysis of 8 cases with primary central nervous system lymphoma].
    Zhou XQ; Liu XQ; Kong JC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):455-7. PubMed ID: 12905861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in primary central nervous system lymphomas.
    Ferreri AJ; Reni M
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):629-49, vi. PubMed ID: 16083827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unusual uterine recurrence of primary central nervous system lymphoma.
    Nichols GL; Jacobson CA; Ferman D; Lichtman SM
    Clin Adv Hematol Oncol; 2006 Sep; 4(9):697-8, discussion 699-700. PubMed ID: 17099627
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical features and diagnosis of primary central nervous system lymphoma.
    Fitzsimmons A; Upchurch K; Batchelor T
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):689-703, vii. PubMed ID: 16083830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and magnetic resonance imaging of a rat model of human B-cell central nervous system lymphoma.
    Soussain C; Muldoon LL; Varallyay C; Jahnke K; DePaula L; Neuwelt EA
    Clin Cancer Res; 2007 Apr; 13(8):2504-11. PubMed ID: 17438111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary central nervous system lymphoma.
    Ferreri AJ; Reni M
    Crit Rev Oncol Hematol; 2007 Sep; 63(3):257-68. PubMed ID: 17590348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system.
    Baraniskin A; Deckert M; Schulte-Altedorneburg G; Schlegel U; Schroers R
    Br J Haematol; 2012 Feb; 156(4):421-32. PubMed ID: 22077417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance features of primary central nervous system lymphoma in the immunocompetent patient: a pictorial essay.
    Yap KK; Sutherland T; Liew E; Tartaglia CJ; Pang M; Trost N
    J Med Imaging Radiat Oncol; 2012 Apr; 56(2):179-86. PubMed ID: 22498191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma.
    Cheng T; Forsyth P; Chaudhry A; Morris D; Glück S; Russell JA; Stewart DA
    Bone Marrow Transplant; 2003 Apr; 31(8):679-85. PubMed ID: 12692608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary central nervous system lymphomas (PCNSL): MRI response criteria revised.
    Küker W; Nägele T; Thiel E; Weller M; Herrlinger U
    Neurology; 2005 Oct; 65(7):1129-31. PubMed ID: 16217075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary CNS lymphoma--an update].
    Soussain C; Houillier C; Choquet S; Hoang-Xuan K
    Bull Cancer; 2014 Mar; 101(3):314-24. PubMed ID: 24691194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary CNS lymphoma.
    Hochberg FH; Baehring JM; Hochberg EP
    Nat Clin Pract Neurol; 2007 Jan; 3(1):24-35. PubMed ID: 17205072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey.
    Haldorsen IS; Krossnes BK; Aarseth JH; Scheie D; Johannesen TB; Mella O; Espeland A
    Cancer; 2007 Oct; 110(8):1803-14. PubMed ID: 17721992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in Norway.
    Salvesen Haldorsen I; Aarseth JH; Hollender A; Larsen JL; Espeland A; Mella O
    Acta Oncol; 2004; 43(6):520-9. PubMed ID: 15370608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual variants of primary central nervous system lymphoma.
    Shenkier TN
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):651-64, vi. PubMed ID: 16083828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of combined-modality therapy for primary and secondary malignant lymphoma of the central nervous system (CNS).
    Kawamura T; Koga S; Okamoto M; Kanno T; Iwamura H
    Radiat Med; 2001; 19(3):145-9. PubMed ID: 11467381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.